Professor Kendall’s special area of research is the delivery of immunotherapeutics, such as vaccines, to the skin without the use of a needle or syringe. He is one of the leading scientists at the Australian Institute for Bioengineering and Nanotechnology. He joined the AIBN from the University of Oxford, where he was associate director of the PowderJect Centre for Gene and Drug Delivery Research, University Research Lecturer in Engineering Science and a Lecturer at Magdalen College. He has published 205 book chapters, journal articles and conference papers, many of them in highly respected scientific journals. He has 96 patents to his credit, with nine more pending.